The existent core technology platforms of VKEY-BIO include KeyTec® TR-FRET and KeyTec® Luminescent. We will develop various new technology platforms closely following research hotspots and demands in the future. Products developed based on these platforms are applied for mechanism research, drug screening and target validation. Notably, our independently developed KeyTec® TR-FRET technology employs specific stable energy donors (Solar Eu/Tb) and acceptors (LA/HX) in a time-resolved fluorescence resonance energy transfer (TR-FRET) system. TR-FRET is known for its characteristics as easy-to-use, homogeneous (no wash), low background interference, wider detection range and robustness. Furthermore, our KeyTec® Luminescent technology is known for its high sensitivity and robust luminescence.
We eagerly anticipate the opportunity to collaborate with you, fostering advancements in life science research together.
VKEY-BIO, founded in 2019, is a biotechnology company dedicated to the research and production of reagents for life sciences. Recognized as a "High-Tech Enterprise," an "Innovative SME," and a "Technology-Based SME" in China, our focus is on providing high-quality reagents. Our mission is to contribute to the reduction of drug discovery costs by offering comprehensive and customized solutions for your research.
Our products primarily based on Luminescent and TR-FRET technology platforms, designed for drugs screening and validation purposes. Notably, our independently developed KeyTec® TR-FRET technology employs the stable energy donor (Solar Eu/Tb) and the stable energy acceptor (LA/HX) in a time-resolved fluorescence resonance energy transfer system. TR-FRET is known for its ease of use, homogeneity (no wash), low background, wide range and robustness. Furthermore, our independently developed KeyTec® Luminescent is known for its high sensitivity and robust luminescence. We eagerly anticipate the opportunity to collaborate with you, fostering advancements in life science research together.
English